About the role
Hgen's mission is to achieve a clean and sustainable energy future through tackling emissions in hard-to-decarbonize industries. By enabling cheap and abundant clean hydrogen, Hgen aims to help decarbonize the more than 10% of global emissions that are best addressed with hydrogen. Learn more about why clean hydrogen is critical for achieving zero-emissions.
As a Senior Controls Systems Engineer, you will lead the design, development, and commissioning of critical control systems that operate our electrolyzers. You will leverage your expertise in controls for safety-critical industrial systems to ensure our electrolyzers meet the highest standards of safety, performance, and reliability. This role offers the opportunity to work in a fast-paced, collaborative startup environment, where your contributions will have a direct impact on the future of decarbonization.
Aplyr's read
Hgen is at the forefront of biotechnology, developing cutting-edge therapies for genetic disorders with a team of specialized engineers and scientists.
What's promising
- •Hgen is pioneering in genetic disorder therapies, offering promising career opportunities in biotechnology.
- •The company has a strong focus on research and development, attracting top talent in engineering and science.
- •Hgen's innovative approach could lead to significant breakthroughs in treating genetic diseases.
What to watch
- •The biotechnology sector can be volatile, affecting job stability and funding.
- •Hgen's success heavily depends on the regulatory approval of its therapies.
- •Limited public information about Hgen's financial health and long-term sustainability.
Why Hgen
- •Hgen specializes in therapies for genetic disorders, setting it apart in the biotech industry.
- •The company employs a diverse team of engineers and scientists, fostering innovation.
- •Hgen's focus on electrochemistry in therapy development is a distinctive approach.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Hgen
Hgen is a biotechnology company focused on developing innovative therapies for genetic disorders and diseases.
